Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,831.00
Bid: 1,833.00
Ask: 1,835.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.109%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,831.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: London Resources Stocks Plunge On Weak Commodities

Tue, 10th Mar 2015 16:58

LONDON (Alliance News) - UK stock indices were the heaviest hit in a global equities market sell-off Tuesday, with just four FTSE 100 stocks making gains, as a strong dollar and weak Chinese data weighed on commodities prices.

London's blue-chip index, which is heavily weighted with resources sector stocks, closed down 2.5% at 6,702.84, marking its worst one-day fall since October 15, while the FTSE 250 fell 1.4% to 16,922.49 and the AIM All-Share index declined 0.6% to 711.63.

European stocks were more resilient than London but still ended lower. The CAC 40 closed down 1.0% and the DAX 30 ended down 0.6%. Wall Street was also down sharply at the close of European equity markets, with the DJIA down 1.5%, the S&P 500 1.4% lower and the Nasdaq Composite down 1.5%.

The dollar continued to strengthen in the wake of strong US jobs data on Friday and the expectations of a summer rate hike by the US Federal Reserve. The Euro fell to a near 12-year low against the greenback at USD1.06963. The Euro was also weakened by the second day of the European Central Bank sovereign bond-purchasing and continued concerns about a possible Greek exit from the eurozone.

"The search for an end to the selling of EUR/USD continues, but with ECB QE in operation it looks like downward pressure will carry the euro ever closer to parity against the dollar. The slow disintegration of the recent Greece deal is not helping either, while most investors are prudently looking to boost dollar holdings at the expense of the euro," said Chris Beauchamp, senior market analyst at IG.

The dollar also rose to its highest level since July 2007 against the Japanese Yen to JPY122.023, but the pound has maintained above the psychological USD1.50.

The strength of the dollar weighed on commodities with oil, in particular, taking a hit. Brent fell to a low of USD56.31 a barrel, its lowest level since February 12, while West Texas Intermediate fell to a low of USD48.42 a barrel.

Oil-related stocks were amongst the worst-performing stocks in the FTSE 100, with Tullow Oil, down 6.2%, the worst performer, and BG Group, down 5.1%, the second-worst performer. Royal Dutch Shell 'B' ended down 4.8%, Weir Group down 3.3%, and BP down 4.0%.

In the FTSE 250, Cairn Energy closed down 7.3%, Premier Oil down 6.8% and SOCO International, down 5.4%.

The FTSE 350 oil and gas producers sector index closed down 4.8%, the worst-performing sector index, followed by the oil equipment services and distribution sector index, which dropped 3.9%.

The mining sector in London was also hit by weak Chinese producer prices. The National Bureau of Statistics said Chinese producer prices declined for the 36th consecutive month in February, weighing heavily on profit margins of companies. Industrial producer prices were down 4.8% from last year, which was bigger than a 4.3% fall seen a month ago. Economists had forecast prices to fall again by 4.3%. This was the biggest fall since October 2009. On a monthly basis, producer prices slid 0.7% after declining 1.1% in January.

Antofagasta ended down 4.3%, Glencore and Rio Tinto both ended down 1.7%, and BHP Billiton closed down 1.5%. In the FTSE 250, Lonmin closed as the worst performer, down 10.0%, while KAZ Minerals closed down 6.8% and Vedanta Resources down 6.9%.

The FTSE 350 mining sector index ended as the third-worst performing sector index, down 3.8%.

Allied Minds, up 7.7%, was one of the best performers in the FTSE 250. The company said it has formed BridgeSat Inc, which will build an optical connectivity system to improve the wireless transfer of data from satellites. BridgeSat co-invented the technology with the US federally-funded Aerospace Corp as part of a commercialisation collaboration.

Inchcape ended up 6.3% after the automotive retailer and distributer said its pretax profit declined due to a writedown on its Russian operations, but the company reported a rise in revenue and hiked its dividend. The company said its pretax profit for 2014 was GBP255.8 million, down from GBP266.1 million last year due to a GBP47.4 million goodwill impairment charge the company booked on its Russian operations. It said it was confident in the long-term potential of the Russian operations, but had reduced its near-term expectations due to the geopolitical uncertainties affecting the country. Still, stripping out exceptional costs, Inchcape's pretax profit rose to GBP303.2 million from GBP274.6 million.

Esure Group, down 9.1%, was the second-worst performer in the FTSE 250. The insurer reported a fall in pretax profit for 2014, blaming motor insurance market conditions and costs related to the acquisition of the remaining parts of GoCompare.

The company said its pretax profit for 2014 was GBP103.3 million, down 13% on the GBP118.4 million posted a year earlier due to the challenging conditions in the motor insurance market and due to costs related to the acquisition of the 50% of price comparison service GoCompare that it did not already own. Gross written premiums fell and the group cut its final dividend.

Optare, up 43%, was the biggest gainer in the AIM All-Share index. The bus maker got a GBP7.3 million order for its Solo single-decker buses from Stagecoach Group in the UK. Optare said it expects to deliver the Solos with Euro 6 emissions standards by the end of this year, although it didn't say how many. It said the order is in addition to five fully electric vehicles that it will deliver this month.

In the economic calendar Wednesday, Chinese retail sales are due at 0530 GMT, European Central Bank President Mario Draghi will be speaking in Frankfurt at 0800 GMT, UK industrial and manufacturing production for January is at 0930 GMT, and US MBA mortgage applications for the week ending March 6 is at 1100 GMT.

In the corporate calendar, drugmaker Hikma Pharmaceuticals, estate agency Foxtons Group, online gaming operator Bwin.party Digital Entertainment, and recruitment company Michael Page International will all be reporting full-year earnings. British home shopping retailer N Brown Group will be issuing a trading statement as will online-only fashion retailer Boohoo.com.

By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.